Ramos, Jessica Fernandes; Leite, Gleice; Martins, Roberta Cristina Ruedas; Rizek, Cibele Saliba 
; Sanabani, Sabri Saeed Al; Rossi, Flavia; Guimaraes, Thais; Levin, Anna Sara Shafferman ; Rocha, Vanderson Geraldo ; Costa, Sílvia Figueiredo
Source: European Journal of Clinical Microbiology & Infectious Diseases. Unidade: FM
Subjects: RESISTÊNCIA MICROBIANA ÀS DROGAS, BACTEREMIA, VIRULÊNCIA, MORTALIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RAMOS, Jessica Fernandes et al. Clinical outcome from hematopoietic cell transplant patients with bloodstream infection caused by carbapenem-resistant P. aeruginosa and the impact of antimicrobial combination in vitro. European Journal of Clinical Microbiology & Infectious Diseases, v. 41, n. 2, p. 313-317, 2022Tradução . . Disponível em: https://doi.org/10.1007/s10096-021-04361-9. Acesso em: 11 nov. 2024.APA
Ramos, J. F., Leite, G., Martins, R. C. R., Rizek, C. S., Sanabani, S. S. A., Rossi, F., et al. (2022). Clinical outcome from hematopoietic cell transplant patients with bloodstream infection caused by carbapenem-resistant P. aeruginosa and the impact of antimicrobial combination in vitro. European Journal of Clinical Microbiology & Infectious Diseases, 41( 2), 313-317. doi:10.1007/s10096-021-04361-9NLM
Ramos JF, Leite G, Martins RCR, Rizek CS, Sanabani SSA, Rossi F, Guimaraes T, Levin ASS, Rocha VG, Costa SF. Clinical outcome from hematopoietic cell transplant patients with bloodstream infection caused by carbapenem-resistant P. aeruginosa and the impact of antimicrobial combination in vitro [Internet]. European Journal of Clinical Microbiology & Infectious Diseases. 2022 ; 41( 2): 313-317.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1007/s10096-021-04361-9Vancouver
Ramos JF, Leite G, Martins RCR, Rizek CS, Sanabani SSA, Rossi F, Guimaraes T, Levin ASS, Rocha VG, Costa SF. Clinical outcome from hematopoietic cell transplant patients with bloodstream infection caused by carbapenem-resistant P. aeruginosa and the impact of antimicrobial combination in vitro [Internet]. European Journal of Clinical Microbiology & Infectious Diseases. 2022 ; 41( 2): 313-317.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1007/s10096-021-04361-9
